Open AccessBrief Report: High Programmatic Isoniazid Preventive Therapy (IPT) Use in Pregnancy Among HIV-Infected Women
Author(s) -
Sylvia M LaCourse,
Anjuli D. Wagner,
Lisa M Cranmer,
Audrey Copeland,
Elizabeth MalecheObimbo,
Barbra A. Richardson,
Daniel Matemo,
John Kinuthia,
Grace JohnStewart
Publication year - 2019
Publication title -
journal of acquired immune deficiency syndromes
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1944-7884
pISSN - 1525-4135
DOI - 10.1097/qai.0000000000002086
Subject(s) - pregnancy , medicine , interquartile range , obstetrics , gestation , postpartum period , confidence interval , pediatrics , genetics , biology
The World Health Organization recommends isoniazid preventive therapy (IPT) for people living with HIV (PLHIV) to prevent tuberculosis (TB), including pregnant women. Recent trial results suggest increased adverse pregnancy outcomes associated with IPT during pregnancy. Data are limited regarding programmatic IPT use in pregnant PLHIV.